Brooks O'Neil
Stock Analyst at Lake Street
(0.95)
# 3,592
Out of 4,784 analysts
35
Total ratings
32.35%
Success rate
-19.31%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRDX Surmodics | Upgrades: Buy | $43 | $30.75 | +39.84% | 4 | Mar 7, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $83.05 | +32.45% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $11.71 | +156.19% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $36.86 | +92.62% | 1 | Jan 24, 2025 | |
| MODV ModivCare | Maintains: Buy | $30 → $10 | $1.40 | +616.85% | 3 | Jan 13, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $20 → $14 | $8.73 | +60.37% | 6 | Jan 8, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $14.42 | +80.31% | 1 | Dec 19, 2024 | |
| LFMD LifeMD | Initiates: Buy | $12 | $5.45 | +120.18% | 1 | Dec 10, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $26.21 | +109.84% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $10.19 | +76.64% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.50 | +11.11% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $75 | $19.28 | +289.00% | 1 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $4.5 | $0.17 | +2,508.70% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $7.54 | +59.15% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $23.34 | +11.40% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $45 | $3.09 | +1,356.73% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $1.10 | +900.00% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $36.55 | +248.84% | 1 | Sep 15, 2020 |
Surmodics
Mar 7, 2025
Upgrades: Buy
Price Target: $43
Current: $30.75
Upside: +39.84%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $83.05
Upside: +32.45%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $11.71
Upside: +156.19%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $36.86
Upside: +92.62%
ModivCare
Jan 13, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $1.40
Upside: +616.85%
AVITA Medical
Jan 8, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $8.73
Upside: +60.37%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $14.42
Upside: +80.31%
LifeMD
Dec 10, 2024
Initiates: Buy
Price Target: $12
Current: $5.45
Upside: +120.18%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $26.21
Upside: +109.84%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $10.19
Upside: +76.64%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $4.50
Upside: +11.11%
May 22, 2024
Maintains: Buy
Price Target: $60 → $75
Current: $19.28
Upside: +289.00%
Mar 14, 2024
Maintains: Buy
Price Target: $9 → $4.5
Current: $0.17
Upside: +2,508.70%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $7.54
Upside: +59.15%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $23.34
Upside: +11.40%
Nov 21, 2022
Assumes: Buy
Price Target: $45
Current: $3.09
Upside: +1,356.73%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $1.10
Upside: +900.00%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $36.55
Upside: +248.84%